Organon Dermatology to present new Phase 3 analysis of VTAMA eczema data at the Society for Pediatric Dermatology annual meeting on July 23, 2026.

The country’s largest lender, State Bank of India (SBI), and 10 other global banks, have combined forces to finance one of ...

We recently compiled a list of the 12 Best Low-Priced Pharma Stocks to Buy Right Now. Organon & Co. (NYSE:OGN) is one of the ...

Sun Pharmaceutical Industries has lined up 11 banks, including State Bank of India (SBI), to finance its $11.75 billion ...

Organon (OGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past ...

After picking up European rights to a pair of Eli Lilly migraine meds in December, Organon, the women’s health-focused spinoff of Merck & Co., is hungry to ink more deals. “It’s not a one-off,” ...

The company has submitted a Form DEFM14A to the SEC, indicating an upcoming shareholder vote. This form gives shareholders all the information they need to develop an informed vote. Read on to learn ...

Five years after launching as a global healthcare company committed to delivering impactful medicines and solutions for a ...

JERSEY CITY, N.J. & SAN FRANCISCO--(BUSINESS WIRE)--Organon (NYSE:OGN) and Sempre Health today announced a strategic partnership designed to motivate eligible patients to refill their prescriptions on ...

Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) -Women health-focused company Organon said on Wednesday it has agreed to buy Roivant's unit Dermavant for up to $1.2 ...

The launch expands Organon’s biosimilars portfolio in Canada to eight products spanning five therapeutic areas.

Sun Pharma expects strong cash flows from the combined business to support debt reduction, innovation investments and growth across specialty medicines, women’s health and global markets.